相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway
Nevertyty M. Mahmoud et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
The application of antidepressant drugs in cancer treatment
Yunxi Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy
Shivangi Patel et al.
METABOLIC BRAIN DISEASE (2022)
Influence of Melatonin Treatment on Cellular Mechanisms of Redox Adaptation in K562 Erythroleukemic Cells
Flaviene Felix Torres et al.
GENES (2022)
The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome
Patricia Diez-Echave et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Melatonin and melatonergic drugs in sleep disorders
Hyung Ki Kim et al.
TRANSLATIONAL AND CLINICAL PHARMACOLOGY (2022)
Sirtuins and the circadian clock interplay in cardioprotection: focus on sirtuin 1
Sanjeev Kumar Soni et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Roles of circadian clocks in cancer pathogenesis and treatment
Yool Lee
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Agomelatine prevents gentamicin nephrotoxicity by attenuating oxidative stress and TLR-4 signaling, and upregulating PPARγ and SIRT1
Ayman M. Mahmoud et al.
LIFE SCIENCES (2021)
Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
Marek Samec et al.
CANCERS (2021)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Circadian rhythms in the absence of the clock gene Bmal1
Sandipan Ray et al.
SCIENCE (2020)
The Dual Role of Serotonin in Colorectal Cancer
Vinicius Kannen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Circadian Genes as Therapeutic Targets in Pancreatic Cancer
Maria Garcia-Costela et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Tanshindiol C inhibits oxidized low-density lipoprotein induced macrophage foam cell formation via a peroxiredoxin 1 dependent pathway
Yuyu Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Transcriptional Regulation by Nrf2
Claudia Tonelli et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors
Jorge Casado et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Melatonin and sirtuins: A not-so unexpected relationship
Juan C. Mayo et al.
JOURNAL OF PINEAL RESEARCH (2017)
Melatonin inhibits colon cancer RKO cell migration by downregulating Rho-associated protein kinase expression via the p38/MAPK signaling pathway
Zhen Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Jiabei Liu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Sirt1 and the Mitochondria
Bor Luen Tang
MOLECULES AND CELLS (2016)
Melatonin: an inhibitor of breast cancer
Steven M. Hill et al.
ENDOCRINE-RELATED CANCER (2015)
SIRT1 Relays Nutritional Inputs to the Circadian Clock Through the Sf1 Neurons of the Ventromedial Hypothalamus
Ricardo Orozco-Solis et al.
ENDOCRINOLOGY (2015)
Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation
Jia-Yi Wei et al.
JOURNAL OF PINEAL RESEARCH (2015)
Targeting aberrant cancer metabolism - The role of sirtuins
Robert Kleszcz et al.
PHARMACOLOGICAL REPORTS (2015)
Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers
Richard E. Kast
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2015)
Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties
B. Guardiola-Lemaitre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Circadian molecular clocks and cancer
Fergal C. Kelleher et al.
CANCER LETTERS (2014)
Molecular mechanisms of the circadian clockwork in mammals
I. Robinson et al.
FEBS LETTERS (2014)
Melatonin reduces endothelin-1 expression and secretion in colon cancer cells through the inactivation of FoxO-1 and NF- KB
Josefa Leon et al.
JOURNAL OF PINEAL RESEARCH (2014)
Antidepressant fluoxetine and its potential against colon tumors
Helga Stopper et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2014)
Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats
Jerome Mairesse et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
p53 regulates Period2 expression and the circadian clock
Takao Miki et al.
NATURE COMMUNICATIONS (2013)
Synergistic mechanisms involved in the antidepressant effects of agomelatine
Daniela Tardito et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer
Josefa Leon et al.
MOLECULAR CARCINOGENESIS (2012)
Peroxiredoxins are conserved markers of circadian rhythms
Rachel S. Edgar et al.
NATURE (2012)
Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation
R. Santoro et al.
ONCOGENE (2012)
The melatonin action on stromal stem cells within pericryptal area in colon cancer model under constant light
Vinicius Kannen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
Brittney Jung-Hynes et al.
JOURNAL OF PINEAL RESEARCH (2010)
CASE HISTORY Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
Christian de Bodinat et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1
Yasukazu Nakahata et al.
SCIENCE (2009)
The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control
Yasukazu Nakahata et al.
CELL (2008)
SIRT1 regulates circadian clock gene expression through PER2 deacetylation
Gad Asher et al.
CELL (2008)
5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction
Xiao-Xin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation:: Implication to tumor biology
Yun-Jeong Kim et al.
CANCER RESEARCH (2007)
The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation
EJ Siddiqui et al.
BJU INTERNATIONAL (2006)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-xL in addition to Bax and p53 status
S Violette et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
